Our assessment: NooCube’s current manufacturer information differs from older versions discussed online. A useful review must identify the version and distinguish research on individual ingredients from evidence for the complete product.
Review method: This update evaluates published product information and research. It does not report a new hands-on trial or laboratory test. Formula information was checked on 10 November 2026; the label supplied with your purchase takes precedence.
Page Contents
Current manufacturer information
The NooCube website describes a caffeine-free Brain Productivity formula and lists 12 ingredients. It reports changes including VitaCholine replacing alpha-GPC and Panax ginseng replacing oat straw. These are manufacturer descriptions, not independent verification of the claimed advantages.
| Selected listed ingredient | Manufacturer-stated amount |
|---|---|
| Bacopa monnieri | 250 mg |
| L-theanine | 100 mg |
| L-tyrosine | 250 mg |
| Choline from VitaCholine | 250 mg |
| Panax ginseng concentrate | 20 mg |
This is a selected snapshot, not a replacement for the full label. Check the exact bottle and regional formulation before comparing amounts. The old review’s formula description and price should not be used as current purchase information.
What counts as evidence for NooCube?
A study on a branded ingredient does not demonstrate that NooCube as a finished blend produces the same outcome. Check whether the amount, formulation and participants match. A testimonial, a guarantee and a manufacturer comparison chart answer different questions from a controlled trial. This review does not claim that we have established the effectiveness of the complete current formula.
Our buying checks
- Read the full supplement-facts panel, including amounts, extract standardisation and warnings.
- Identify which cited studies concern the complete product and which concern ingredients.
- Compare cost per labelled serving with delivery and subscription terms included.
- Have a pharmacist review overlapping ingredients if you already take a blend or medication.
Editorial conclusion
The current formula should be evaluated on its own merits, rather than an old label or a “no side effects” promise. Caffeine-free is a useful product characteristic for comparison; it does not establish safety. We have removed the earlier broad verdict and outdated ingredient framing in favour of a dated source-based assessment.
This assessment does not establish that the product treats ADHD, depression, dementia or brain injury. Check the current label and discuss suitability with a qualified professional if you take medicines or have a health condition.



